Nicht aus der Schweiz? Besuchen Sie lehmanns.de
The Sanford Guide to Antimicrobial Therapy 2024 - David N. Gilbert, Henry F. Chambers, Michael S. Saag, Andrew T. Pavia, Helen W. Boucher

The Sanford Guide to Antimicrobial Therapy 2024

Pocket Edition
Buch | Softcover
2024 | 54. Auflage
Antimicrobial Therapy (Verlag)
978-1-944272-26-5 (ISBN)
CHF 55,90 inkl. MwSt
Sanford Guide helps you make the best infectious diseases treatment decisions, fast.

With Sanford Guide, you get:

  • Clinically actionable, concise answers—we give you exactly what you need to make the best decision in a fast-paced setting.
  • Institutionally diverse editorial team by design—not every organization has the same patient population, budget, or processes. We bring perspectives from many medical institutions.

Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The »Sanford Guide to Antimicrobial Therapy« provides convenient, concise, and reliable information.

The book includes a FREE 1-month trial of Sanford Guide All Access, which provides expanded content, interactive tables and tools, and constant updates.

Coverage includes
  • Clinical syndromes:
    Pathogens: Bacterial, Fungal, Mycobacterial, Parasitic, Viral
  • Anti-infective agents:
    Dosing: Pediatric adjustments, Renal adjustments; Adverse effects, Activity, Pharmacology, Interactions
  • Preventative therapy

What's New for 2024:

We have updated treatment recommendations throughout this edition based on recent references and guidelines. Drugs approved by the FDA since the last edition are included in various tables throughout the edition. Also, we have removed many older references that have been superseded or are simply no longer necessary.

Major updates include:
  • Table 1—Updated with many changes, as always
  • Table 4—Updated legend to better explain the colors/symbols used to denote activity of antibacterial agents
  • Table 5—Updated based on evolving recommendations for treatment of highly resistant bacteria, especially gram-negatives
  • Table 8—Updated to reflect the new FDA risk categorization as well as available data on antimicrobial use during lactation
  • Table 14A—Updated to include recommendations for treatment, prophylaxis and prevention of COVID-19
  • Table 16—Updated to cover all antimicrobials approved for pediatric use
  • Table 17A—Updated to include SLED (sustained low efficiency dialysis) dosing
  • Table 21—New table summarizing U.S. Travel Vaccination Recommendations
Mehr entdecken
aus dem Bereich